NATCO PHARMA LTD. - 524816 - Board Meeting Intimation for Notice Of Board Meeting Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve 1. To consider the Unaudited Financial Results for the quarter and nine months ended 31st December 2021 2. To consider third interim dividend, if any, for the financial year 2021-2022.05-02-2022